To determine the level of CLPTM1L protein expression in ovarian serous adenocarcinoma, we conducted immunohistochemistry on frozen histology sections of treatment-naïve tumors from 24 patients. This evidence concerns the gene CLPTM1L and ovarian serous adenocarcinoma.